|
US3941790A
(en)
*
|
1967-07-03 |
1976-03-02 |
National Research Development Corporation |
Bis diketopiperazines
|
|
FR2092556A5
(de)
|
1970-04-02 |
1972-01-21 |
Snam Progetti |
|
|
GB1353304A
(en)
|
1971-03-30 |
1974-05-15 |
Sagami Chem Res |
Process for production of diketopiperazine dihydroxamates and intermediate therefor
|
|
US4006261A
(en)
*
|
1973-09-28 |
1977-02-01 |
Firmenich S.A. |
Flavoring with mixtures of theobromine and cyclic dipeptides
|
|
US3928330A
(en)
|
1973-12-19 |
1975-12-23 |
Ciba Geigy Corp |
Substituted piperazinedione carboxylic acids and metal salts thereof
|
|
GB1459488A
(en)
*
|
1974-03-19 |
1976-12-22 |
Wyeth John & Brother Ltd |
Piperazinedione derivatives
|
|
JPS5225019Y1
(de)
|
1974-12-19 |
1977-06-07 |
|
|
|
US4088649A
(en)
*
|
1975-07-02 |
1978-05-09 |
Firmenich S.A. |
Process for preparing a diketo-piperazine
|
|
JPS5225019A
(en)
|
1975-08-19 |
1977-02-24 |
New Zealand Inventions Dev |
Production of serum albumin
|
|
US4205057A
(en)
*
|
1978-01-17 |
1980-05-27 |
Government Of The United States |
Cerebrospinal fluid protein fragments
|
|
JPS6236331Y2
(de)
|
1979-05-16 |
1987-09-16 |
|
|
|
DE2940654A1
(de)
*
|
1979-10-06 |
1981-04-16 |
Bayer Ag, 5090 Leverkusen |
Dimeres keten der 1,2,,-triazol-3-carbonsaeure
|
|
US4289759A
(en)
|
1980-06-23 |
1981-09-15 |
Ortho Pharmaceutical Corporation |
Immunoregulatory diketopiperazine compounds
|
|
US4331595A
(en)
*
|
1980-06-23 |
1982-05-25 |
Ortho Pharmaceutical Corporation |
Immunoregulatory diketopiperazine compounds
|
|
JPS5836225U
(ja)
|
1981-08-31 |
1983-03-09 |
株式会社東芝 |
金属製平パレツト
|
|
JPS5973574A
(ja)
|
1982-10-21 |
1984-04-25 |
Grelan Pharmaceut Co Ltd |
環状ジペプチド類
|
|
JPS5973574U
(ja)
|
1982-11-10 |
1984-05-18 |
三菱自動車工業株式会社 |
電磁式燃料噴射装置
|
|
US4694061A
(en)
*
|
1983-10-12 |
1987-09-15 |
Ciba-Geigy Corporation |
Radiation-sensitive polycondensates, processes for their preparation coated material and its use
|
|
US4656190A
(en)
*
|
1983-11-14 |
1987-04-07 |
Merck & Co., Inc. |
Indene derivatives and their use as PAF-antagonists
|
|
NZ212051A
(en)
*
|
1984-05-18 |
1988-10-28 |
Univ Australian |
Immune response suppression; certain epipolythio- dioxopiperazine derivatives and their preparation
|
|
DE3435972A1
(de)
*
|
1984-10-01 |
1986-04-10 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
|
|
JPS61112060A
(ja)
*
|
1984-11-02 |
1986-05-30 |
Fujisawa Pharmaceut Co Ltd |
ピペラジン化合物
|
|
US4806538A
(en)
|
1984-11-02 |
1989-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperazine compound as PAF-antagonist
|
|
GB8427735D0
(en)
*
|
1984-11-02 |
1984-12-12 |
Fujisawa Pharmaceutical Co |
Piperazine compound
|
|
JPH0245309Y2
(de)
|
1984-12-21 |
1990-11-30 |
|
|
|
CS254868B1
(cs)
*
|
1985-06-11 |
1988-02-15 |
Jiri Vanzura |
Způsob výroby cyklických dipeptidů
|
|
JPS6236331A
(ja)
|
1985-08-12 |
1987-02-17 |
Kenji Suzuki |
抗感染症剤ならびに免疫賦活剤
|
|
US4661500A
(en)
*
|
1985-08-29 |
1987-04-28 |
Roman Rozencwaig |
Method of medical treatment with serotonin antagonists
|
|
US4771056A
(en)
*
|
1985-08-29 |
1988-09-13 |
Roman Rozencwaig |
Method of medical treatment with serotonin antagonists
|
|
US5047401A
(en)
*
|
1985-09-09 |
1991-09-10 |
Board Of Regents, The University Of Texas System |
Use of dipeptide alkyl esters to treat GVHD
|
|
US4694081A
(en)
*
|
1985-09-23 |
1987-09-15 |
Monsanto Company |
Process to prepare 2,5-diketopiperazines
|
|
PT83613B
(en)
|
1985-10-28 |
1988-11-21 |
Lilly Co Eli |
Process for the selective chemical removal of a protein amino-terminal residue
|
|
JPS63290868A
(ja)
|
1987-05-22 |
1988-11-28 |
Fujisawa Pharmaceut Co Ltd |
ジケトピペラジン誘導体およびその塩類
|
|
JPS6413075A
(en)
|
1987-07-03 |
1989-01-17 |
Nippon Chemiphar Co |
Production of 2, 5-piperazinedione derivative
|
|
US5512544A
(en)
*
|
1987-09-13 |
1996-04-30 |
Yeda Research And Development Co. Ltd. |
Pharmaceutical compositions comprising an anticytokine
|
|
MY104933A
(en)
*
|
1987-09-30 |
1994-07-30 |
Pfizer Ltd |
Platelet activating factor antagonists
|
|
US4992552A
(en)
|
1988-08-31 |
1991-02-12 |
Eastman Kodak Company |
Process for preparation of amino acids
|
|
US5144073A
(en)
*
|
1988-08-31 |
1992-09-01 |
Hubbs John C |
Process for preparation of dipeptides
|
|
JP2001055340A
(ja)
|
1988-10-31 |
2001-02-27 |
Welfide Corp |
アルブミン製剤の製造方法
|
|
US5238938A
(en)
*
|
1989-02-10 |
1993-08-24 |
Otsuka Pharmaceutical Co., Ltd. |
Indole derivatives
|
|
DE3906952A1
(de)
*
|
1989-03-04 |
1990-09-06 |
Boehringer Mannheim Gmbh |
(3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
|
|
US5902790A
(en)
|
1995-10-03 |
1999-05-11 |
Cytran, Inc. |
Pharmaceutical angiostatic dipeptide compositions and method of use thereof
|
|
EP0422282B1
(de)
|
1989-10-13 |
1995-04-05 |
Phobos N.V. |
Verfahren zur kontinuierlichen Herstellung von hochmolekularen Polyester-Harzen
|
|
JPH03176478A
(ja)
|
1989-12-05 |
1991-07-31 |
Snow Brand Milk Prod Co Ltd |
新規なジケトピペラジン誘導体及びこれを有効成分とする免疫抑制剤
|
|
CA2060515A1
(en)
|
1990-03-15 |
1991-09-16 |
John B. Hill |
Process for manufacturing aspartame from a diketopiperazine and novel intermediates and derivatives therefor
|
|
US6180616B1
(en)
*
|
1990-05-10 |
2001-01-30 |
Atsuo F. Fukunaga |
Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function
|
|
US6099856A
(en)
|
1992-06-15 |
2000-08-08 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
|
US5578323A
(en)
*
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
|
US5693338A
(en)
*
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
|
US6331318B1
(en)
*
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
|
GB9022543D0
(en)
*
|
1990-10-17 |
1990-11-28 |
Wellcome Found |
Antibody production
|
|
AU646522B2
(en)
|
1990-11-14 |
1994-02-24 |
University Company Pty Limited, The |
Diagnosis and treatment of multiple sclerosis
|
|
US5776892A
(en)
|
1990-12-21 |
1998-07-07 |
Curative Health Services, Inc. |
Anti-inflammatory peptides
|
|
JPH04234374A
(ja)
|
1990-12-27 |
1992-08-24 |
Ajinomoto Co Inc |
ジケトピペラジン誘導体の製造方法
|
|
GB9102997D0
(en)
|
1991-02-13 |
1991-03-27 |
Pfizer Ltd |
Therapeutic agents
|
|
US5543503A
(en)
*
|
1991-03-29 |
1996-08-06 |
Genentech Inc. |
Antibodies to human IL-8 type A receptor
|
|
US5538993A
(en)
*
|
1991-09-12 |
1996-07-23 |
Yissum Research Development Company |
Certain tetrahydrocannabinol-7-oic acid derivatives
|
|
AU2905092A
(en)
|
1991-10-28 |
1993-06-07 |
Cytoven |
Pharmaceutical dipeptide compositions and methods of use thereof
|
|
JPH05244982A
(ja)
*
|
1991-12-06 |
1993-09-24 |
Sumitomo Chem Co Ltd |
擬人化ｂ−ｂ１０
|
|
JPH05163148A
(ja)
|
1991-12-18 |
1993-06-29 |
Kanebo Ltd |
抗腫瘍剤
|
|
GB9200210D0
(en)
|
1992-01-07 |
1992-02-26 |
British Bio Technology |
Compounds
|
|
DE4201147A1
(de)
|
1992-01-17 |
1993-07-22 |
Boehringer Ingelheim Kg |
Verwendung von paf-antagonisten hetrazepinoider struktur zur behandlung der allergischen rhinitis und verwandter indikationen
|
|
US5352461A
(en)
|
1992-03-11 |
1994-10-04 |
Pharmaceutical Discovery Corporation |
Self assembling diketopiperazine drug delivery system
|
|
JP3176478B2
(ja)
|
1992-05-29 |
2001-06-18 |
いすゞ自動車株式会社 |
居眠り運転防止装置
|
|
US5418218A
(en)
*
|
1992-07-10 |
1995-05-23 |
The University Of Maryland At Baltimore |
Histidyl-proline diketopiperazine (cyclo his-pro) a cns-active pharmacologic agent
|
|
US5648486A
(en)
|
1992-07-13 |
1997-07-15 |
Cytomed, Inc. |
Compounds and methods for the treatment of inflammatory and immune disorders
|
|
US5463083A
(en)
|
1992-07-13 |
1995-10-31 |
Cytomed, Inc. |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
US5358938A
(en)
|
1992-07-13 |
1994-10-25 |
Cytomed, Inc. |
Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
|
|
US5434151A
(en)
|
1992-08-24 |
1995-07-18 |
Cytomed, Inc. |
Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
|
|
GB9217331D0
(en)
|
1992-08-14 |
1992-09-30 |
Xenova Ltd |
Pharmaceutical compounds
|
|
AU5016793A
(en)
|
1992-08-20 |
1994-03-15 |
Cytomed, Inc |
Dual functional anti-inflammatory and immunosuppressive agents
|
|
US5728553A
(en)
*
|
1992-09-23 |
1998-03-17 |
Delta Biotechnology Limited |
High purity albumin and method of producing
|
|
EP0674661B1
(de)
*
|
1992-12-18 |
2003-07-02 |
Molecular Rx., Inc. |
Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
|
|
ES2068742B1
(es)
|
1993-02-11 |
1995-11-16 |
Uriach & Cia Sa J |
Nuevos derivados de piridinio.
|
|
WO1994020063A2
(en)
|
1993-03-04 |
1994-09-15 |
Cytoven International N.V. |
Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
|
|
US6107050A
(en)
*
|
1993-05-03 |
2000-08-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Diagnostic test for alzheimers disease
|
|
GB9310756D0
(en)
*
|
1993-05-25 |
1993-07-14 |
Glaxo Lab Sa |
Compositions
|
|
CA2167805A1
(en)
|
1993-07-23 |
1995-02-02 |
L. David Tomei |
Methods of treating apoptosis and associated conditions
|
|
GB9324872D0
(en)
*
|
1993-12-03 |
1994-01-19 |
Univ Pasteur |
Pharmaceutical compounds
|
|
IL112627A0
(en)
*
|
1994-02-14 |
1995-05-26 |
Xenova Ltd |
Diketopiperazines, their preparation and pharmaceutical or veterinary compositions containing them
|
|
JP2921731B2
(ja)
*
|
1994-03-10 |
1999-07-19 |
日清製油株式会社 |
有機溶媒または油脂類のゲル化剤
|
|
FR2717484A1
(fr)
*
|
1994-03-16 |
1995-09-22 |
Pf Medicament |
Nouveaux composés pseudo-bis-peptidiques analogues de la CCK, leur procédé de préparation, leur utilisation à titre de médicament et les compositions pharmaceutiques les comprenant .
|
|
GB9410387D0
(en)
|
1994-05-24 |
1994-07-13 |
Xenova Ltd |
Pharmaceutical compounds
|
|
US5550132A
(en)
*
|
1994-06-22 |
1996-08-27 |
University Of North Carolina |
Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines
|
|
WO1996000391A1
(en)
*
|
1994-06-23 |
1996-01-04 |
Affymax Technologies N.V. |
Methods for the synthesis of diketopiperazines
|
|
US5817751A
(en)
*
|
1994-06-23 |
1998-10-06 |
Affymax Technologies N.V. |
Method for synthesis of diketopiperazine and diketomorpholine derivatives
|
|
US5990112A
(en)
|
1996-06-18 |
1999-11-23 |
Affymax Technologies N.V. |
Inhibitors of metalloproteases pharmaceutical compositions comprising same and methods of their use
|
|
US5750565A
(en)
|
1995-05-25 |
1998-05-12 |
Cytomed, Inc. |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
EE9600184A
(et)
|
1994-06-27 |
1997-06-16 |
Cytomed, Inc. |
Kardiovaskulaar-, inflammatoor- ja immuunhaiguste raviühendid ja -meetodid
|
|
US5792776A
(en)
|
1994-06-27 |
1998-08-11 |
Cytomed, Inc., |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
US5703093A
(en)
|
1995-05-31 |
1997-12-30 |
Cytomed, Inc. |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
EP0801065A4
(de)
*
|
1994-07-29 |
1998-02-25 |
Nikken Chemicals Co Ltd |
1,4-dihydropyridinverbindungen und sie enthaltende medizinische zusammensetzungen
|
|
US5561115A
(en)
|
1994-08-10 |
1996-10-01 |
Bayer Corporation |
Low temperature albumin fractionation using sodium caprylate as a partitioning agent
|
|
DE69528773T2
(de)
*
|
1994-10-05 |
2003-09-04 |
Cari Loder |
Behandlung von multipler sklerose (ms) und anderen demyelinisationserkrankungen unter verwendung von lofepramin in kombination mit l-phenylalamin, tyrosin oder tryptophan und evtl. einer vitamin b12-verbindung
|
|
ES2087038B1
(es)
*
|
1994-11-07 |
1997-03-16 |
Uriach & Cia Sa J |
Nuevas piperidinas con actividad antagonista del paf.
|
|
CZ280726B6
(cs)
|
1994-11-16 |
1996-04-17 |
Galena, A.S. |
Pentapeptidické prekurzory biologicky účinných cyklických dipeptidů
|
|
WO1996016947A1
(en)
|
1994-12-01 |
1996-06-06 |
Toyama Chemical Co., Ltd. |
Novel 2,3-diketopiperazine derivative or salt thereof
|
|
JP3634891B2
(ja)
|
1995-04-06 |
2005-03-30 |
株式会社海洋バイオテクノロジー研究所 |
キチナーゼ阻害物質
|
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
AU6311996A
(en)
*
|
1995-07-06 |
1997-02-05 |
Zeneca Limited |
Peptide inhibitors of fibronectine
|
|
US5811241A
(en)
|
1995-09-13 |
1998-09-22 |
Cortech, Inc. |
Method for preparing and identifying N-substitued 1,4-piperazines and N-substituted 1,4-piperazinediones
|
|
US5665714A
(en)
*
|
1995-12-07 |
1997-09-09 |
Clarion Pharmaceuticals Inc. |
N-substituted glycerophosphoethanolamines
|
|
US6060452A
(en)
|
1996-03-13 |
2000-05-09 |
Cytran, Inc. |
Analogs of L-Glu-L-Trp having pharmacological activity
|
|
US6541224B2
(en)
*
|
1996-03-14 |
2003-04-01 |
Human Genome Sciences, Inc. |
Tumor necrosis factor delta polypeptides
|
|
JP2000507576A
(ja)
|
1996-04-03 |
2000-06-20 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質トランスフェラーゼ阻害剤
|
|
WO1997038011A1
(en)
|
1996-04-03 |
1997-10-16 |
Pepresearch A/S |
Non-dendritic backbone peptide carrier
|
|
US5919785A
(en)
*
|
1996-04-03 |
1999-07-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997038688A1
(en)
*
|
1996-04-12 |
1997-10-23 |
Peptide Technology Pty. Limited |
Methods of treating immunopathologies using polyunsaturated fattyacids
|
|
US5932579A
(en)
|
1996-06-18 |
1999-08-03 |
Affymax Technologies N.V. |
Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use
|
|
US5985581A
(en)
*
|
1996-07-25 |
1999-11-16 |
The Mclean Hospital Corporation |
Use of presenilin-1 for diagnosis of alzheimers disease
|
|
WO1998009968A1
(en)
|
1996-09-09 |
1998-03-12 |
Novartis Animal Health Australasia Pty. Limited |
Terpenylated diketopiperazines, (drimentines)
|
|
NZ335544A
(en)
|
1996-10-04 |
2001-08-31 |
Neuronz Ltd |
Use of GPE (tripeptide or dipeptide) in form of Gly-Pro-Glu or Gly-Pro or Pro-Glu as a neuromodulator
|
|
RU2125728C1
(ru)
|
1996-10-10 |
1999-01-27 |
Пермская государственная медицинская академия |
Способ иммунодиагностики рассеянного склероза
|
|
EP0835660A1
(de)
|
1996-10-14 |
1998-04-15 |
Gaston Edmond Filomena Merckx |
Zusammensetzungen enthaltend Methylcobalamin für die Behandlung von Muliple Sklerosis oder andere demyleinisierende Krankheiten
|
|
US6441172B1
(en)
*
|
1996-11-07 |
2002-08-27 |
Torrey Pines Institute For Molecular Studies |
Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
|
|
US5932112A
(en)
*
|
1996-11-27 |
1999-08-03 |
Browning Transport Management, Inc. |
Method and apparatus for killing microorganisms in ship ballast water
|
|
RU2112242C1
(ru)
|
1996-12-09 |
1998-05-27 |
Пермская государственная медицинская академия |
Способ диагностики рассеянного склероза
|
|
JPH10226615A
(ja)
*
|
1997-02-18 |
1998-08-25 |
Pola Chem Ind Inc |
アスパラギン酸フェニルアラニン環状ジペプタイド誘導体を含有する組成物
|
|
JPH10245315A
(ja)
*
|
1997-03-05 |
1998-09-14 |
Pola Chem Ind Inc |
シクロジペプタイド誘導体を含有する組成物
|
|
US6306909B1
(en)
*
|
1997-03-12 |
2001-10-23 |
Queen's University At Kingston |
Anti-epileptogenic agents
|
|
WO1998040748A1
(en)
|
1997-03-14 |
1998-09-17 |
Neuromark |
Diagnosing neurologic disorders
|
|
US6265535B1
(en)
*
|
1997-05-30 |
2001-07-24 |
The Trustees Of The University Of Pennsylvania |
Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses
|
|
RU2128840C1
(ru)
|
1997-06-16 |
1999-04-10 |
Пермская государственная медицинская академия |
Способ диагностики рассеянного склероза
|
|
US6222029B1
(en)
*
|
1997-08-01 |
2001-04-24 |
Genset |
5′ ESTs for secreted proteins expressed in brain
|
|
US5834032A
(en)
*
|
1997-08-11 |
1998-11-10 |
Song; Moon K. |
Compositions and methods for treating diabetes
|
|
US7202279B1
(en)
|
1998-02-11 |
2007-04-10 |
Georgetown University |
Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
|
|
EP0939124A3
(de)
|
1998-02-24 |
2001-03-21 |
Smithkline Beecham Plc |
MBGP1-Sequenzen
|
|
AU3370099A
(en)
|
1998-03-31 |
1999-10-18 |
Mayo Foundation For Medical Education And Research |
Use of platelet activating factor (paf) inhibitors to inhibit il-5 induced eosinophil activation or degranulation
|
|
CA2326760A1
(en)
|
1998-04-03 |
1999-10-14 |
Cytran, Ltd. |
Use of l-glu-l-trp in the treatment of hiv infection
|
|
AU3467099A
(en)
*
|
1998-04-03 |
1999-10-25 |
Cytran Ltd. |
Methods for production of therapeutic cytokines
|
|
AU767241B2
(en)
*
|
1998-09-14 |
2003-11-06 |
Qiang Xu |
Immunosuppressive agents
|
|
DE69939121D1
(de)
|
1998-10-02 |
2008-08-28 |
Ischemia Tech Inc |
Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden
|
|
WO2000020840A1
(en)
|
1998-10-02 |
2000-04-13 |
Ischemia Technologies, Inc. |
Tests for the rapid evaluation of ischemic states and kits
|
|
US6461875B1
(en)
*
|
1998-10-02 |
2002-10-08 |
Ischemia Technologies, Inc. |
Test for rapid evaluation of ischemic states and kit
|
|
US6492179B1
(en)
|
1998-10-02 |
2002-12-10 |
Ischemia Techologies, Inc. |
Test for rapid evaluation of ischemic states and kit
|
|
US6475743B1
(en)
*
|
1998-10-02 |
2002-11-05 |
Ischemia Technologies, Inc. |
Marker useful for detection and measurement of free radical damage and method
|
|
DE19847690A1
(de)
|
1998-10-15 |
2000-04-20 |
Brahms Diagnostica Gmbh |
Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
|
|
US6358957B1
(en)
|
1998-11-12 |
2002-03-19 |
Nereus Pharmaceuticals, Inc. |
Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
|
|
US7026322B2
(en)
|
1998-11-12 |
2006-04-11 |
Nereus Pharmaceuticals, Inc. |
Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
|
|
AU3074500A
(en)
|
1999-01-20 |
2000-08-07 |
Kyowa Hakko Kogyo Co. Ltd. |
Proteasome inhibitors
|
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
AU3760400A
(en)
|
1999-03-19 |
2000-10-09 |
Vanderbilt University |
Methods and reagents for the diagnosis and treatment of multiple sclerosis
|
|
US6090780A
(en)
*
|
1999-04-07 |
2000-07-18 |
Chandon Prasad |
Histidyl-proline diketopiperazine and method of use
|
|
US6689765B2
(en)
*
|
1999-05-04 |
2004-02-10 |
Schering Corporation |
Piperazine derivatives useful as CCR5 antagonists
|
|
JP2000327575A
(ja)
|
1999-05-26 |
2000-11-28 |
Teika Seiyaku Kk |
ジケトピペラジン誘導体含有炎症疾患治療剤および新規なジケトピペラジン誘導体
|
|
DE19937721A1
(de)
*
|
1999-08-10 |
2001-02-15 |
Max Planck Gesellschaft |
Neue Diketopiperazine
|
|
BR0015539A
(pt)
|
1999-11-12 |
2002-07-16 |
Wyeth Corp |
Adamantil e noradamantil aril- e aralquilpiperazinas ramificadas com atividade 5-ht1a de serotonina
|
|
WO2001036351A2
(en)
*
|
1999-11-19 |
2001-05-25 |
Corvas International, Inc. |
Plasminogen activator inhibitor antagonists related applications
|
|
US20050096323A1
(en)
*
|
1999-11-30 |
2005-05-05 |
Novoscience Pharma Inc. |
Diketopiperazine derivatives to inhibit thrombin
|
|
AU2001236005A1
(en)
|
2000-02-29 |
2001-09-12 |
Chugai Seiyaku Kabushiki Kaisha |
Preparations stabilized over long time
|
|
DE10019879A1
(de)
*
|
2000-04-20 |
2001-10-25 |
Degussa |
Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
|
|
HUP0302358A3
(en)
|
2000-05-09 |
2007-09-28 |
Adpharma |
Piperazinedione compounds and use of them for producing pharmaceutical compositions
|
|
US7288545B2
(en)
|
2000-05-09 |
2007-10-30 |
Angiorx Corporation |
Piperazinedione compounds
|
|
DE10026998A1
(de)
|
2000-05-31 |
2001-12-13 |
Fresenius Kabi De Gmbh |
Verfahren zur Herstellung einer kosmetischen Zusammensetzung, die humanes Serum Albumin umfasst, welches aus transgenen nicht-menschlichen Säugern erhalten wurde
|
|
US20030153575A1
(en)
*
|
2000-06-08 |
2003-08-14 |
Orme Mark W. |
Tetracyclic diketopiperazine compounds as pdev inhibitors
|
|
EP1311277A4
(de)
*
|
2000-07-18 |
2004-08-25 |
Joslin Diabetes Center Inc |
Methoden zur fibrose-modulation
|
|
CZ20002681A3
(cs)
|
2000-07-21 |
2002-03-13 |
Ev®En Ing. Csc. Kasafírek |
Cyklické tyrosinové dipeptidy
|
|
CZ20002680A3
(cs)
|
2000-07-21 |
2002-03-13 |
Ev®En Ing. Csc. Kasafírek |
Cyklické alkylthiopeptidy
|
|
CA2774959C
(en)
|
2000-08-04 |
2016-05-31 |
Dmi Biosciences, Inc. |
Method of using diketopiperazines and composition containing them
|
|
AU2001284697A1
(en)
*
|
2000-08-04 |
2002-02-18 |
Dmi Biosciences, Inc. |
Method of synthesizing diketopiperazines
|
|
US20070208087A1
(en)
*
|
2001-11-02 |
2007-09-06 |
Sanders Virginia J |
Compounds, compositions and methods for the treatment of inflammatory diseases
|
|
US6815214B2
(en)
*
|
2000-12-29 |
2004-11-09 |
Celltech R & D, Inc. |
Pharmaceutical uses and synthesis of diketopiperazines
|
|
GB2372740A
(en)
|
2001-01-17 |
2002-09-04 |
Xenova Ltd |
Diketopiperazines
|
|
JP2004532386A
(ja)
|
2001-01-26 |
2004-10-21 |
オックスフォード グリコサイエンシズ（ユーケー）リミテッド |
多発性硬化症を診断および治療するためのタンパク質、遺伝子、およびこれらの使用
|
|
WO2002083667A2
(en)
|
2001-04-13 |
2002-10-24 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
|
|
ATE409181T1
(de)
|
2001-05-08 |
2008-10-15 |
Univ Yale |
Proteomimetische verbindungen und verfahren
|
|
US7368421B2
(en)
*
|
2001-06-27 |
2008-05-06 |
Probiodrug Ag |
Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
|
|
AU2002332122A1
(en)
|
2001-10-15 |
2003-04-28 |
The Medstar Research Institute |
Modulation of akt-dependent response to prevent restenosis
|
|
US20040063654A1
(en)
*
|
2001-11-02 |
2004-04-01 |
Davis Mark E. |
Methods and compositions for therapeutic use of RNA interference
|
|
AU2002368202B2
(en)
*
|
2001-11-02 |
2008-06-05 |
Insert Therapeutics, Inc |
Methods and compositions for therapeutic use of RNA interference
|
|
GB0128108D0
(en)
|
2001-11-23 |
2002-01-16 |
Astrazeneca Ab |
Therapeutic use
|
|
ATE497013T1
(de)
|
2001-12-27 |
2011-02-15 |
Ajinomoto Kk |
Verfahren zur herstellung von glutaminsäurederivaten
|
|
MXPA04006929A
(es)
*
|
2002-01-18 |
2004-12-06 |
Unilever Nv |
Composiciones cosmeticas comprendiendo un compuesto de ciclodipeptido.
|
|
CA2480832A1
(en)
*
|
2002-04-05 |
2003-10-23 |
Nitromed, Inc. |
Nitric oxide donors, compositions and methods of use
|
|
ES2204294B2
(es)
|
2002-07-02 |
2005-02-01 |
Universidade De Santiago De Compostela |
Nuevos antibioticos activos frente al vibrio anguillarum y sus aplicaciones en cultivos de peces, crustaceos, moluscos y otras actividades de acuicultura.
|
|
US20040038865A1
(en)
*
|
2002-08-01 |
2004-02-26 |
Mannkind Corporation |
Cell transport compositions and uses thereof
|
|
US20080260838A1
(en)
*
|
2003-08-01 |
2008-10-23 |
Mannkind Corporation |
Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
|
|
US7919497B2
(en)
*
|
2002-08-02 |
2011-04-05 |
Nereus Pharmaceuticals, Inc. |
Analogs of dehydrophenylahistins and their therapeutic use
|
|
DK1529044T5
(da)
|
2002-08-02 |
2008-04-21 |
Nereus Pharmaceuticals Inc |
Dehydrophenylahistiner og analoger deraf og syntesen af dehydrophenylahistiner og analoger deraf
|
|
KR20050042146A
(ko)
*
|
2002-08-06 |
2005-05-04 |
아플라겐 게엠베하 |
결합 분자
|
|
DE10238144A1
(de)
|
2002-08-15 |
2004-02-26 |
Basf Ag |
Verwendung von Diketopiperazin-Derivaten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
|
|
AU2003270087B2
(en)
*
|
2002-09-03 |
2009-04-23 |
Georgetown University |
Akt inhibitors, pharmaceutical compositions, and uses thereof
|
|
US7575929B2
(en)
|
2002-10-02 |
2009-08-18 |
Dmi Life Sciences, Inc. |
Diagnosis of multiple sclerosis with diketopiperazines
|
|
US7196169B2
(en)
|
2002-10-11 |
2007-03-27 |
Queen's University At Kingston |
Isolated post-translationally modified mammalian proteins for monitoring and diagnosing muscle damage
|
|
AU2003281978A1
(en)
|
2002-11-22 |
2004-06-18 |
Boehringer Ingelheim International Gmbh |
2,5-diketopiperazines for the treatment of obesity
|
|
CN103191409A
(zh)
*
|
2003-05-15 |
2013-07-10 |
Dmi生物科学公司 |
T-细胞介导的疾病的治疗
|
|
KR20060037409A
(ko)
*
|
2003-07-30 |
2006-05-03 |
제논 파마슈티칼스 인크. |
피페라진 유도체 및 그의 치료제로서의 용도
|
|
DK1664050T3
(en)
*
|
2003-09-03 |
2016-03-07 |
Neuren Pharmaceuticals Ltd |
Neuroprotective bicyclic compounds and pharmaceutical compositions containing them
|
|
US7776867B2
(en)
|
2004-06-29 |
2010-08-17 |
Amgen Inc. |
Furanopyrimidines
|
|
JP4970260B2
(ja)
|
2004-08-20 |
2012-07-04 |
プロメティック バイオサイエンシズ，リミテッド |
親和性クロマトグラフィーによるタンパク質の逐次的単離および精製スキーム
|
|
US20070065483A1
(en)
|
2005-09-21 |
2007-03-22 |
Chudzik Stephen J |
In vivo formed matrices including natural biodegradable polysaccharides and uses thereof
|
|
US20080017576A1
(en)
*
|
2006-06-15 |
2008-01-24 |
Rensselaer Polytechnic Institute |
Global model for optimizing crossflow microfiltration and ultrafiltration processes
|
|
CA2657578A1
(en)
|
2006-07-11 |
2008-01-17 |
Harkness Pharmaceuticals, Inc. |
Methods of treating obesity using satiety factors
|
|
US8231929B2
(en)
|
2006-11-09 |
2012-07-31 |
Cook Medical Technologies Llc |
Medical device coating process
|
|
US20090038416A1
(en)
|
2007-08-07 |
2009-02-12 |
Aleta Behrman Bonner |
System and method for biological sample collection and analyte detection
|
|
CN101808515A
(zh)
|
2007-09-25 |
2010-08-18 |
雅培制药有限公司 |
作为趋化因子受体拮抗剂的八氢并环戊二烯化合物
|
|
US20090163936A1
(en)
|
2007-12-21 |
2009-06-25 |
Chunlin Yang |
Coated Tissue Engineering Scaffold
|
|
US20100042206A1
(en)
|
2008-03-04 |
2010-02-18 |
Icon Medical Corp. |
Bioabsorbable coatings for medical devices
|
|
WO2009114725A2
(en)
|
2008-03-12 |
2009-09-17 |
Children's Hospital Medical Center |
Mobilization of hematopoietic stem cells
|
|
US8217047B2
(en)
|
2008-05-27 |
2012-07-10 |
Dmi Acquisition Corp. |
Therapeutic methods and compounds
|
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
|
BR112012009450A2
(pt)
|
2009-10-30 |
2017-05-23 |
Novozymes Biopharma Dk As |
variantes de albumina
|
|
CA2810844C
(en)
|
2010-09-07 |
2017-03-21 |
Dmi Acquisition Corp. |
Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
|
|
MX343160B
(es)
*
|
2010-09-07 |
2016-10-26 |
Ampio Pharmaceuticals Inc |
Dicetopiperazinas para uso en inhibir hiperpermeabilidad vascular.
|
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
|
CA2846598C
(en)
|
2011-10-10 |
2019-12-10 |
Ampio Pharmaceuticals, Inc. |
Treatment of degenerative joint disease
|
|
EP2765968A4
(de)
|
2011-10-10 |
2015-01-21 |
Ampio Pharmaceuticals Inc |
Implantierbare medizinprodukte mit erhöhter immuntoleranz sowie verfahren zur herstellung und implantation
|
|
HK1198812A1
(en)
|
2011-10-28 |
2015-06-12 |
Ampio Pharmaceuticals, Inc. |
Treatment of rhinitis
|
|
JP3176478U
(ja)
|
2012-04-11 |
2012-06-21 |
ネイス株式会社 |
運動用エアートランポリン
|
|
US20150366932A1
(en)
|
2013-02-01 |
2015-12-24 |
Ampio Pharmaceuticals, Inc. |
Methods for producing diketopiperazines and compositions containing diketopiperazines
|
|
EA201500943A1
(ru)
|
2013-03-15 |
2016-08-31 |
Ампио Фармасьютикалс, Инк. |
Составы для мобилизации, хоуминга, размножения и дифференцировки стволовых клеток и способы применения составов
|
|
CA2958080A1
(en)
|
2014-08-18 |
2016-02-25 |
Ampio Pharmaceuticals, Inc. |
Treatment of joint conditions
|
|
US11389512B2
(en)
|
2015-06-22 |
2022-07-19 |
Ampio Pharmaceuticals, Inc. |
Use of low molecular weight fractions of human serum albumin in treating diseases
|